| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Director | Common Stock | 35.4K | $648K | $18.33 | May 15, 2025 | Direct |
| ADC Therapeutics SA | Director | Common Shares | 93.6K | $335K | $3.58 | Jun 13, 2025 | Direct |
| Deciphera Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | $0 | $10.58 | Jun 11, 2024 | Direct |
| Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 15, 2025 | Direct |